Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.

This research article presents a comparative study of vitamin K(1) 2,3-epoxide reductase (VKOR) activity across several species, including how this activity is affected by warfarin. Significant differences were observed between species which suggests varying susceptibility to warfarin.

Objective and Approach

• The main goal was to analyze and compare VKOR activity in bovine, canine, equine, human, murine, ovine, porcine, and rat hepatic microsomes. This is an important research approach considering the role VKOR plays in metabolizing vitamin K and in blood clotting.
• In addition to monitoring VKOR activity across these species, the study measured the IC(50) of warfarin, a medicine used for preventing blood clots, in human, murine, porcine, and rat hepatic microsomes. IC(50) represents the concentration of a drug required to inhibit the biological or biochemical function of a particular enzyme by half. It is a crucial measure of drug potency.

Findings and Comparisons

• The differences in VKOR activity across the studied species were evaluated in terms of kinetic constants K(m app), V(max), and Cl(int app). K(m app) refers to the substrate concentration when the rate of the reaction is half of the maximum speed, V(max). Cl(int app) refers to the intrinsic clearance or rate at which the enzyme metabolizes the substrate in vitro.
• Significant inter-species differences emerged, particularly in terms of the IC(50) values of warfarin where the murine microsomes (0.17 microM) showed a significantly higher value compared to rat microsomes (0.07 microM). That difference points towards a higher susceptibility towards warfarin for rats compared to mice.

Importance and Implications

• This research is pivotal in understanding variations in drug metabolism and effects across different species. This is particularly relevant to pharmaceutical research, where the efficacy and safety of drugs are tested across different species before human consumption.
• Notably, the differences in susceptibility to warfarin observed between rat and mouse models suggest that different animal models may respond differently to the same medication, emphasizing the significance of cross-species studies in drug testing and development.